Report copyright - KESARI - Recent Progress in Brain Tumors...Concurrent temozolomide 75 mg/m 2 6-12 cycles of temozolomide 150-200 mg/m2 • Median survival 14.6 vs. 12.1 months • 2-year survival
Please pass captcha verification before submit form
Please pass captcha verification before submit form